Corporate crime in the pharmaceutical industry:
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
London
Routledge
2013
|
| Schriftenreihe: | Routledge revivals
|
| Schlagwörter: | |
| Links: | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=649600 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=649600 |
| Beschreibung: | First published in 1984 by Routledge & Kegan Paul |
| Umfang: | 1 Online-Ressource (viii, 440 Seiten) |
| ISBN: | 9781135072896 1135072892 9780415815628 0415815622 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042740271 | ||
| 003 | DE-604 | ||
| 005 | 20170111 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150806s2013 xx o|||| 00||| eng d | ||
| 020 | |a 9781135072896 |c electronic bk. |9 978-1-135-07289-6 | ||
| 020 | |a 1135072892 |c electronic bk. |9 1-135-07289-2 | ||
| 020 | |a 9780415815628 |9 978-0-415-81562-8 | ||
| 020 | |a 0415815622 |9 0-415-81562-2 | ||
| 035 | |a (ZDB-4-NLEBK)649600 | ||
| 035 | |a (OCoLC)860711177 | ||
| 035 | |a (DE-599)BVBBV042740271 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 338.476151 |2 23 | |
| 100 | 1 | |a Braithwaite, John |d 1951- |e Verfasser |0 (DE-588)131504258 |4 aut | |
| 245 | 1 | 0 | |a Corporate crime in the pharmaceutical industry |c John Braithwaite |
| 264 | 1 | |a London |b Routledge |c 2013 | |
| 300 | |a 1 Online-Ressource (viii, 440 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 340 | |a Online-Ressource | ||
| 490 | 0 | |a Routledge revivals | |
| 500 | |a First published in 1984 by Routledge & Kegan Paul | ||
| 505 | 8 | |a Includes bibliographical references and index | |
| 505 | 8 | |a First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally | |
| 650 | 7 | |a BUSINESS & ECONOMICS / Industries / General |2 bisacsh | |
| 650 | 7 | |a Commercial crimes |2 fast | |
| 650 | 7 | |a Pharmaceutical industry / Corrupt practices |2 fast | |
| 650 | 4 | |a Industrie | |
| 650 | 4 | |a Wirtschaft | |
| 650 | 4 | |a Pharmaceutical industry |x Corrupt practices | |
| 650 | 4 | |a Commercial crimes | |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirtschaftskriminalität |0 (DE-588)4066464-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Straftat |0 (DE-588)4057799-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4522595-3 |a Fallstudiensammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Wirtschaftskriminalität |0 (DE-588)4066464-8 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 689 | 1 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 1 | |a Straftat |0 (DE-588)4057799-5 |D s |
| 689 | 1 | |8 3\p |5 DE-604 | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=649600 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-NLEBK | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028171142 | |
| 966 | e | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=649600 |l DE-91 |p ZDB-4-NLEBK |q TUM_PDA_EBSCOBAE_Kauf |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| DE-BY-TUM_katkey | 2124909 |
|---|---|
| _version_ | 1821932213785067520 |
| any_adam_object | |
| author | Braithwaite, John 1951- |
| author_GND | (DE-588)131504258 |
| author_facet | Braithwaite, John 1951- |
| author_role | aut |
| author_sort | Braithwaite, John 1951- |
| author_variant | j b jb |
| building | Verbundindex |
| bvnumber | BV042740271 |
| collection | ZDB-4-NLEBK |
| contents | Includes bibliographical references and index First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally |
| ctrlnum | (ZDB-4-NLEBK)649600 (OCoLC)860711177 (DE-599)BVBBV042740271 |
| dewey-full | 338.476151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.476151 |
| dewey-search | 338.476151 |
| dewey-sort | 3338.476151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03334nam a2200649zc 4500</leader><controlfield tag="001">BV042740271</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170111 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150806s2013 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781135072896</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-135-07289-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1135072892</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-135-07289-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780415815628</subfield><subfield code="9">978-0-415-81562-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0415815622</subfield><subfield code="9">0-415-81562-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)649600</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)860711177</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042740271</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.476151</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Braithwaite, John</subfield><subfield code="d">1951-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)131504258</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Corporate crime in the pharmaceutical industry</subfield><subfield code="c">John Braithwaite</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Routledge</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (viii, 440 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="340" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Routledge revivals</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">First published in 1984 by Routledge & Kegan Paul</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Industries / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Commercial crimes</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry / Corrupt practices</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wirtschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Corrupt practices</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Commercial crimes</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirtschaftskriminalität</subfield><subfield code="0">(DE-588)4066464-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Straftat</subfield><subfield code="0">(DE-588)4057799-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4522595-3</subfield><subfield code="a">Fallstudiensammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wirtschaftskriminalität</subfield><subfield code="0">(DE-588)4066464-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Straftat</subfield><subfield code="0">(DE-588)4057799-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=649600</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028171142</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=649600</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCOBAE_Kauf</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4522595-3 Fallstudiensammlung gnd-content |
| genre_facet | Fallstudiensammlung |
| id | DE-604.BV042740271 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T17:18:38Z |
| institution | BVB |
| isbn | 9781135072896 1135072892 9780415815628 0415815622 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028171142 |
| oclc_num | 860711177 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (viii, 440 Seiten) |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCOBAE_Kauf |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Routledge |
| record_format | marc |
| series2 | Routledge revivals |
| spellingShingle | Braithwaite, John 1951- Corporate crime in the pharmaceutical industry Includes bibliographical references and index First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally BUSINESS & ECONOMICS / Industries / General bisacsh Commercial crimes fast Pharmaceutical industry / Corrupt practices fast Industrie Wirtschaft Pharmaceutical industry Corrupt practices Commercial crimes Pharmazeutische Industrie (DE-588)4045696-1 gnd Wirtschaftskriminalität (DE-588)4066464-8 gnd Straftat (DE-588)4057799-5 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4066464-8 (DE-588)4057799-5 (DE-588)4522595-3 |
| title | Corporate crime in the pharmaceutical industry |
| title_auth | Corporate crime in the pharmaceutical industry |
| title_exact_search | Corporate crime in the pharmaceutical industry |
| title_full | Corporate crime in the pharmaceutical industry John Braithwaite |
| title_fullStr | Corporate crime in the pharmaceutical industry John Braithwaite |
| title_full_unstemmed | Corporate crime in the pharmaceutical industry John Braithwaite |
| title_short | Corporate crime in the pharmaceutical industry |
| title_sort | corporate crime in the pharmaceutical industry |
| topic | BUSINESS & ECONOMICS / Industries / General bisacsh Commercial crimes fast Pharmaceutical industry / Corrupt practices fast Industrie Wirtschaft Pharmaceutical industry Corrupt practices Commercial crimes Pharmazeutische Industrie (DE-588)4045696-1 gnd Wirtschaftskriminalität (DE-588)4066464-8 gnd Straftat (DE-588)4057799-5 gnd |
| topic_facet | BUSINESS & ECONOMICS / Industries / General Commercial crimes Pharmaceutical industry / Corrupt practices Industrie Wirtschaft Pharmaceutical industry Corrupt practices Pharmazeutische Industrie Wirtschaftskriminalität Straftat Fallstudiensammlung |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=649600 |
| work_keys_str_mv | AT braithwaitejohn corporatecrimeinthepharmaceuticalindustry |